159
Participants
Start Date
March 31, 2011
Primary Completion Date
June 30, 2012
Study Completion Date
June 30, 2012
Cis-UCA 2.5% emulsion cream
2.5% cis-UCA in emulsion cream base twice daily, amount of a fingertip per one hand (i.e. palm + thumb + fingers) area, applied topically as a thin layer on the affected skin area of approximate size of maximally three hand areas for up to 28 days (one fingertip per one hand area)
Cis-UCA 5% emulsion cream
5% cis-UCA in emulsion cream base twice daily, amount of a fingertip per one hand (i.e. palm + thumb + fingers) area, applied topically as a thin layer on the affected skin area of approximate size of maximally three hand areas for up to 28 days (one fingertip per one hand area)
Placebo for cis-UCA emulsion cream
The placebo for cis-UCA product (emulsion cream base) twice daily, amount of a fingertip per one hand area applied topically as a thin layer on the affected skin area on of approximate size of maximally three hand areas for up to 28 days (one fingertip per one hand area).
Protopic® 0.1% ointment
0.1% Protopic® twice daily, amount of a fingertip per one hand area applied topically as a thin layer on the affected skin area of approximate size of maximally three hand areas for up to 28 days (one fingertip per one hand area).
Helsinki University Central Hospital, Skin and Allergy Hospital, Helsinki
Mehiläinen Medical Center Kuopio, Kuopio
Lohja Hospital, Clinic of Dermatology and Allergology, Lohja
Mehiläinen Medical Center Turku, Turku
Pulssi Medical Center, Turku
Turku University Hospital, Department of Dermatology and Venereal Diseases, Turku
FinnMedi Oy, Tampere
Lead Sponsor
BioCis Pharma Ltd
INDUSTRY